Litcius/Paper detail

Experience with milatuzumab, an anti-CD74 antibody against immunomodulatory macrophage migration inhibitory factor (MIF) receptor, for systemic lupus erythematosus (SLE)

Daniel J. Wallace, Florence Figueras, William A. Wegener, David M. Goldenberg

2021Annals of the Rheumatic Diseases40 citationsDOI

Topics & Concepts

Macrophage migration inhibitory factorImmunologyMedicineCD74CytokinePeripheral blood mononuclear cellAntibodyAutoimmunityAntigenMHC class IIMajor histocompatibility complexIn vitroBiologyBiochemistryMacrophage Migration Inhibitory FactorGalectins and Cancer BiologyNuclear Receptors and Signaling
Experience with milatuzumab, an anti-CD74 antibody against immunomodulatory macrophage migration inhibitory factor (MIF) receptor, for systemic lupus erythematosus (SLE) | Litcius